Takashi Sohda
Takashi Sohda publishes mostly in Organic Chemistry, Molecular Biology and Biochemistry, on topics such as Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds and Eicosanoids and Hypertension Pharmacology.
- World rank
- #1,424,082 of 7,710,434 ranked researchers
- Rank in Japan
- #22,225 of 383,136
- Works
- 53
- Citations
- 2.3k
- Citations per work
- 43.3
What does Takashi Sohda research?
Takashi Sohda's work is mostly in Chemistry (50%), Biochemistry, Genetics and Molecular Biology (26%), Medicine (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences2649.7%
- Chemistry2649.7%
- Life Sciences1425.5%
- Everything else815.3%
- Health Sciences59.5%
- Medicine59.5%
- 1Organic Chemistry50% of their works
- 2Molecular Biology17% of their works
- 3Biochemistry9% of their works
- 4Oncology4% of their works
- 5Pharmacology3% of their works
- 6Physiology2% of their works
Research topics
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Eicosanoids and Hypertension Pharmacology
- Peroxisome Proliferator-Activated Receptors
- Metabolism, Diabetes, and Cancer
- Synthesis and Reactions of Organic Compounds
- Bone Metabolism and Diseases
- Synthesis and Biological Evaluation
Which keywords describe Takashi Sohda's research?
The keywords of their largest research topics: Heterocyclic Compounds, Medicinal Chemistry, Synthesis, Tubulin Inhibitors, Vascular Targeting Agents, Heterocycles, Inflammation and Metabolism.
- Quinoxaline
- Bone Resorption
- Oxazolones
- Imidazoles
- Peroxisome Proliferator-Activated Receptors
- Epoxyeicosatrienoic Acids
- Arachidonic Acid
- Antimicrobial
- Metabolism
- Heterocycles
- Tubulin Inhibitors
- Medicinal Chemistry
- Heterocyclic Compounds
- Synthesis
- Vascular Targeting Agents
- Inflammation
- Biological Evaluation
- Triazines
- Catalyst
- PPARs
- AMP-Activated Protein Kinase
- Metformin
- Antimicrobial Activity
- Osteoclast Differentiation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Heterocyclic Compounds262 topics
- Medicinal Chemistry262 topics
- Synthesis253 topics
- Tubulin Inhibitors221 topic
- Vascular Targeting Agents221 topic
- Heterocycles212 topics
- Inflammation202 topics
- Metabolism202 topics
- Biological Evaluation192 topics
- Antimicrobial151 topic
- Triazines151 topic
- Arachidonic Acid101 topic
- Catalyst102 topics
- Epoxyeicosatrienoic Acids101 topic
- PPARs101 topic
- Peroxisome Proliferator-Activated Receptors101 topic
- AMP-Activated Protein Kinase61 topic
- Imidazoles61 topic
- Metformin61 topic
- Oxazolones61 topic
- Antimicrobial Activity41 topic
- Bone Resorption41 topic
- Osteoclast Differentiation41 topic
- Quinoxaline41 topic
Where does Takashi Sohda work?
Takashi Sohda's main affiliation in the publication record is Takeda (Japan), Japan.
How many publications and citations does Takashi Sohda have?
OpenAlex counts 53 works and 2,294 citations for Takashi Sohda, an h-index of 20, ranking #1,424,082 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Takashi Sohda. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.